P15 VALIDATION OF THE NOVEL EUROPEAN MYELOMA NETWORK PROGNOSTIC SCORE (R2-ISS) IN AN INDEPENDENT REAL-WORLD SETTING

por Cengiz Seval, G, Aydoğan, M, Akbulut, MH, Karakaya, B, Yavuz, G, Yilmaz, H, Beksac, M
Publicado 2023

P19 EXTERNAL VALIDATION OF THREE EXISTING EARLY MYELOMA RELAPSE SCORES (BY EBMT, CIBMTR, AND GIMEMA) IN A SINGLE CENTER SHOWS MAJOR DIFFERENCES

por Beksac, M, Cengiz Seval, G, Civriz Bozdag, S, Toprak, SK, Kurt Yuksel, M, Topcuoglu, P, Arslan, O, Ozcan, M, Demirer, T, Ilhan, O, Gurman, G
Publicado 2023

PB2074: IBRUTINIB AS A PROMISING TREATMENT FOR WALDENSTRÖM MACROGLOBULINEMIA

por Ilhan, O., Cengiz Seval, G., Avcu, F., Ferhanoglu, B., Ozcan, M., Cetin, G., Kurtoglu, E., Yilmaz, H., Atalay, F., Gulturk, E., Nalcaci, M., Beksac, M.
Publicado 2022